Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Sympathetic activation is thought to contribute to the inflammatory process associated with obesity, which is characterized by elevated circulating C-reactive protein (hsCRP) and interleukin-6 (IL-6). To evaluate whether sympathetic activation is associated with inflammation in the absence of obesity, we studied patients with postural tachycardia syndrome (POTS), a condition characterized by increased sympathetic tone in otherwise healthy individuals. Compared with 23 lean controls, 43 lean female POTS had greater vascular sympathetic modulation (low-frequency blood pressure variability, LF SBP, 3.2 ± 0.4 vs. 5.5 ± 0.6 mmHg 2, respectively, P = 0.006), lower cardiac parasympathetic modulation (high-frequency heart rate variability, 1,414 ± 398 vs. 369 ± 66 ms 2, P = 0.001), and increased serum IL-6 (2.33 ± 0.49 vs. 4.15 ± 0.54 pg/ml, P = 0.011), but this was not associated with increases in hsCRP, which was low in both groups (0.69 ± 0.15 vs. 0.82 ± 0.16 mg/l, P = 0.736). To explore the contribution of adiposity to inflammation, we then compared 13 obese female POTS patients and 17 obese female controls to matched lean counterparts (13 POTS and 11 controls). Compared with lean controls, obese controls had increased LF SBP(3.3 ± 0.5 vs. 7.0 ± 1.1 mmHg 2; P = 0.016), IL-6 (2.15 ± 0.58 vs. 3.92 ± 0.43 pg/ml; P = 0.030) and hsCRP (0.69 ± 0.20 vs. 3.47 ± 0.72 mg/l; P = 0.001). Obese and lean POTS had similarly high IL-6 but only obese POTS had increased hsCRP (5.76 ± 1.99 mg/l vs. 0.65 ± 0.26; P < 0.001). In conclusion, sympathetic activation in POTS is associated with increased IL-6 even in the absence of obesity. The coupling between IL-6 and CRP, however, requires increased adiposity, likely through release of IL-6 by visceral fat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909 · cited 1×
“Muscle is an important source of IL-6, mostly during exercise (41), but our levels were taken with patients supine at rest.”
BackgroundInterleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Physiology and immunology of the cholinergic antiinflammatory pathway
Tracey, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30555 · Cited by 1,563 · cited 1×
“A possible explanation of this association may be an impaired “cholinergic anti-inflammatory pathway” (56).”
BackgroundVisceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 2×
“OBESITY is a state of chronic low-grade inflammation characterized by increased circulating inflammatory markers such as interleukin-6 (IL-6) and C-reactive protein (CRP) (11, 14, 34).”
BackgroundDimensional assessment of chronic fatigue syndrome
Vercoulen, J. H. M. M., Swanink, C. M. A., Fennis, J. F. M., Galama, J. M. D., van der Meer, J. W. M., & Bleijenberg, G. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90099-x · Cited by 1,306
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“Of interest, increased IL-6 may act in the central nervous system to induce sympathetic activation (55, 59), raising the possibility of a positive feedback loop between the SNS and this inflammatory cytokine.”
BackgroundSympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614 · cited 2×
“Hence, our findings support the notion that sympathetic activation of adipose tissue contributes to the elevated circulating IL-6 in obesity (27, 33).”
BackgroundSympathetic Neural Activation in Visceral Obesity
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002) · Circulation · doi:10.1161/01.cir.0000041244.79165.25 · Cited by 557 · cited 1×
“The sympathetic nervous system (SNS) activity is augmented in obesity, and central sympathetic outflow is positively correlated with indexes of adiposity, in particular visceral fat (2, 27).”
BackgroundMeasuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin
Shah, N. R., & Braverman, E. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033308 · Cited by 554 · cited 1×
“Although BMI strongly correlates with direct measures of adiposity such as total body fat, visceral adipose tissue, and subcutaneous adipose tissue (7, 9, 31, 51), factors such as age, sex, and lean mass can influence the relationship between BMI and adiposity (9, 22, 51).”
BackgroundBrunner, E. J., Hemingway, H., Walker, B. R., Page, M., Clarke, P., Juneja, M., Shipley, M. J., Kumari, M., Andrew, R., Seckl, J. R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000038364.26310.bd · Cited by 539 · cited 1×
“Decreased vagal tone, on the other hand, has also been associated with elevated levels of IL-6 in patients with congestive heart failure and the metabolic syndrome (5, 8).”
BackgroundThe neuropathic postural tachycardia syndrome
Jacob, G., Costa, F., Shannon, J. R., Robertson, R. M., Wathen, M., Stein, M., Biaggioni, I., Ertl, A., Black, B., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010053431404 · Cited by 398 · cited 3×
“Given this heterogeneity, it is likely that sympathetic activation is not distributed homogeneously to all vascular beds (29).”
BackgroundResultSelf-citationAcute mental stress elicits delayed increases in circulating inflammatory cytokine levels
STEPTOE, A., WILLEMSEN, G., OWEN, N., FLOWER, L., & MOHAMED-ALI, V. (2001) · Clinical Science · doi:10.1042/cs1010185 · Cited by 354 · cited 1×
“Previous studies have shown that acute sympathetic activation can increase circulating IL-6 levels in lean and obese healthy subjects, for example with mental stress or through -adrenergic stimulation with isoproterenol (25, 54).”
BackgroundRaj, S. R., Biaggioni, I., Yamhure, P. C., Black, B. K., Paranjape, S. Y., Byrne, D. W., & Robertson, D. (2005) · Circulation · doi:10.1161/01.cir.0000160356.97313.5d · Cited by 286 · cited 1×
“Plasma aldosterone was measured by radioimmunoassay (45).”
Self-citationElenkov, I. J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.037 · Cited by 273 · cited 1×
“Circulating proinflammatory cytokines may act centrally to increase sympathetic drive (55, 59), and to induce behavioral changes such as depression, hyperalgesia, sleep disturbances, and cognitive impairment (“sickness response”) (12).”
BackgroundPlasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R., & Kopin, I. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113298 · Cited by 245 · cited 1×
“Concentrations of norepinephrine were measured by batch alumina extraction followed by high-performance liquid chromatography for separation with electrochemical detection and quantification (24).”
MethodChronic Orthostatic Intolerance: A Disorder With Discordant Cardiac and Vascular Sympathetic Control
Furlan, R., Jacob, G., Snell, M., Robertson, D., Porta, A., Harris, P., & Mosqueda-Garcia, R. (1998) · Circulation · doi:10.1161/01.cir.98.20.2154 · Cited by 229
Raj, S. R., Black, B. K., Biaggioni, I., Paranjape, S. Y., Ramirez, M., Dupont, W. D., & Robertson, D. (2009) · Circulation · doi:10.1161/circulationaha.108.846501 · Cited by 225 · cited 1×
“This is in agreement with other studies (17, 21, 29, 38, 44), and our previous observations that POTS patients have an exaggerated decrease in BP induced by ganglionic blockade (30), and that the orthostatic tachycardia is responsive to -blockade (4, 46).”
ResultSelf-citationThe hemodynamic and neurohumoral phenotype of postural tachycardia syndrome
Garland, E. M., Raj, S. R., Black, B. K., Harris, P. A., & Robertson, D. (2007) · Neurology · doi:10.1212/01.wnl.0000267663.05398.40 · Cited by 159
Self-citationAutonomic Contribution to Blood Pressure and Metabolism in Obesity
Shibao, C., Gamboa, A., Diedrich, A., Ertl, A. C., Chen, K. Y., Byrne, D. W., Farley, G., Paranjape, S. Y., Davis, S. N., & Biaggioni, I. (2007) · Hypertension · doi:10.1161/01.hyp.0000251679.87348.05 · Cited by 147 · cited 1×
“agreement as to whether LFSBP reflects sympathetic modulation of vascular tone (18, 39, 40, 49), we have previously shown that LFSBP is increased in obese hypertensives (19, 20, 52), decreased in patients with pure autonomic failure, virtually abolished by autonomic ganglionic blockade (10, 20, 52), and was also great…”
Self-citationNeurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes
Okamoto, L. E., Raj, S. R., Peltier, A., Gamboa, A., Shibao, C., Diedrich, A., Black, B. K., Robertson, D., & Biaggioni, I. (2012) · Clinical Science · doi:10.1042/cs20110200 · Cited by 89 · cited 5×
“A diagnosis of POTS was based on the following criteria: 1) a history of daily orthostatic symptoms for at least 6 mo; 2) heart rate increase of 30 beats/min within the first 10 min of standing; 3) the absence of orthostatic hypotension (defined as a fall in BP 20/10 mmHg); and 4) the absence of conditions that can ex…”
BackgroundMethodResultInfluentialSelf-citationBaroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome
Muenter Swift, N., Charkoudian, N., Dotson, R. M., Suarez, G. A., & Low, P. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01243.2004 · Cited by 70 · cited 1×
“This probably explains why direct measurements of sympathetic nerve activity directed to muscle vasculature (MSNA) during orthostatic challenge were found to be increased in some (36), but not in other studies (17).”
ResultJordan, J., Shannon, J. R., Diedrich, A., Black, B. K., & Robertson, D. (2002) · Hypertension · doi:10.1161/hy1201.097202 · Cited by 69 · cited 1×
“This is in agreement with other studies (17, 21, 29, 38, 44), and our previous observations that POTS patients have an exaggerated decrease in BP induced by ganglionic blockade (30), and that the orthostatic tachycardia is responsive to -blockade (4, 46).”
ResultSelf-citationLow-dose propranolol and exercise capacity in postural tachycardia syndrome: A randomized study
Arnold, A. C., Okamoto, L. E., Diedrich, A., Paranjape, S. Y., Raj, S. R., Biaggioni, I., & Gamboa, A. (2013) · Neurology · doi:10.1212/wnl.0b013e318293e310 · Cited by 65 · cited 1×
“This is in agreement with other studies (17, 21, 29, 38, 44), and our previous observations that POTS patients have an exaggerated decrease in BP induced by ganglionic blockade (30), and that the orthostatic tachycardia is responsive to -blockade (4, 46).”
ResultSelf-citationNeuronal and hormonal perturbations in postural tachycardia syndrome
Mar, P. L., & Raj, S. R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00220 · Cited by 52
Self-citationAutonomic Blockade Improves Insulin Sensitivity in Obese Subjects
Gamboa, A., Okamoto, L. E., Arnold, A. C., Figueroa, R. A., Diedrich, A., Raj, S. R., Paranjape, S. Y., Farley, G., Abumrad, N., & Biaggioni, I. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03738 · Cited by 45
Self-citation
Cited by
Postural tachycardia syndrome – Diagnosis, physiology, and prognosis
Arnold, A. C., Ng, J., & Raj, S. R. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.02.005 · Cited by 186
Self-citationAutoimmunity in postural orthostatic tachycardia syndrome: Current understanding
Vernino, S., & Stiles, L. E. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.04.005 · Cited by 107
Smith, E. C., Diedrich, A., Raj, S. R., Gamboa, A., Shibao, C. A., Black, B. K., Peltier, A., Paranjape, S. Y., Biaggioni, I., & Okamoto, L. E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016196 · Cited by 16
Self-citation
Metadata
- Authors
- Okamoto, L. E., Raj, S. R., Gamboa, A., Shibao, C. A., Arnold, A. C., Garland, E. M., Black, B. K., Farley, G., Diedrich, A., & Biaggioni, I.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2015-12-15
- Volume
- 309
- Issue
- 12
- Pages
- H2098-H2107
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W2291341206
- Cited by
- 57
- References
- 26
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.